Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Latrepirdine

No Benefit for Dimebon in Huntington’s

An antihistamine that failed to work in Alzheimer’s disease also fell short of expectations in Huntington’s disease, researchers reported.

In a randomized controlled trial, latrepirdine (Dimebon) didn’t improve cognition or global function compared with placebo, Ray Dorsey, MD, of Johns Hopkins, and colleagues reported online in the Archives of Neurology.

Currently, medications can mitigate… No Benefit for Dimebon in Huntington’s   



Parkinson’s Disease Dementia

memantine1 - abnormal blood clotting1 - department of psychiatry and psychotherapy1 - uncategorized1 - neurodegenerative conditions1 - igf-11 - amyloid plaque4 - regular caffeine consumption1 - methamphetamine1 - anoea1 - late-day anxiety1 - hypertension3 - bucknill1 - mental function1 - degenerationist hypothesis1 - physical weakness1 - body mass index2 - meryl streep1 - professor lewy1 - examination of handwriting1 - people with parkinsons1 - progression of parkinson's1 - ßsecretase-11 - mini-cognitive assessment1 - signs of alzheimer's1 - physical exercise1 - hypertension and dementia1 - postitron emission tomography1 - structural changes1 - dbs1 -